Metformin effervescent - EffRx

Drug Profile

Metformin effervescent - EffRx

Alternative Names: effervescent metformin oral solution - EffRx; EX-404

Latest Information Update: 07 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EffRx
  • Class Antihyperglycaemics; Biguanides; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Polycystic ovary syndrome
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Polycystic ovary syndrome

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 07 Dec 2015 Phase-II/III clinical trials in Polycystic ovary syndrome (In adults) in USA (PO)
  • 10 Jun 2014 Preclinical trials in Polycystic ovary syndrome (In adolescents) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top